This article explains the 4 shifts enabling faster, lower-risk, commercially successful biologics technology transfer.
News|Articles|May 15, 2015
- Pharmaceutical Technology-05-15-2015
- Volume 2015 eBook
- Issue 2
Disposable Technology versus Traditional Stainless Steel--When Time Means Money
Author(s)Susanne Resatz, PhD
The use of disposables requires careful consideration and planning.
Advertisement
Disposables offer many advantages in clinical manufacturing, such as speeding up time-to-clinic by preventing the need for cleaning validation. In addition, precious API that are often in short supply during early development can be saved. The use of disposables, however, requires careful consideration and planning.
Download
Articles in this issue
over 11 years ago
Validating and Implementing a Rapid Sterility Testing Methodover 11 years ago
Cleanroom and Facility Planning: Getting Beyond Cost Per Square Footover 11 years ago
Aging Facilities: Aseptic Manufacturing Faces the FutureAdvertisement
Related to this article
The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
The Leadership Summit will bring senior pharma executives together to discuss supply chain resilience, medicine security, and manufacturing capacity amid growing geopolitical fragmentation.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement